Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Global Hemp Group Inc C.GHG

Alternate Symbol(s):  GBHPF

Consumer Defensive Farm Products
Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Company’s has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology.


CSE:GHG - Post by User

Global Hemp Group Inc
Bullboard Posts
User Avatar Image
(77)
•••
Comment by GoodOutlook2015on Jan 09, 2018 10:07am
103 Views
Post# 27312860

RE:Cannabidiol (CBD) is projected to be a billion-dollar market

RE:Cannabidiol (CBD) is projected to be a billion-dollar market
TheBiochemist wrote: Without the influence of CBD Oil and Cannabis infusion, according to Markets and Markets , the nutraceutical ingredients market alone is projected to grow at a CAGR of 7.5% from 2016 to 2022 to reach USD 445.58 Billion by 2022. Cannabidiol (CBD) is projected to be a billion-dollar market in just three years, according to a new report by Brightfield Group. The data company estimates that hemp CBD sales have already hit $170 million in 2016 and a 55% compound annual growth rate over the next five years will cause the market to crack the billion-dollar mark. Combining the two together, the infusion of nutraceuticals into the CBD - Cannabinoid space is providing new opportunities for enhanced revenues and global distribution. 

https://www.theglobeandmail.com/investing/markets/stocks/OGI-X/pressreleases/302795/


GHG is a potential target for OGI or GW Pharma....

Best Regards, 

The Biochemist



I have seen this compared to he valuations of CGH and Aurora in 2 to three years... well Canapy Growth in 43.34 right now .... I can wait please please please please. https://web.tmxmoney.com/quote.php?qm_symbol=WEED&locale=EN
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities